Not Signed In -
Sulfonylureas |
Sulfonylureas Products |
| Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study.(Clinical Care/Education/Nutrition) : An article from: Diabetes Care Philippe Moulin, Marie Andre, Hasan Alawi, Lelita C. dos Santos, Abdul K. Khalid, Dragomir Koev, Ray Moore, Viorel Serban, Brigitte Picandet, Marie Francillard Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.(Emerging ... : An article from: Diabetes Care David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis D. Kim, Mark S. Fineman, Alain D. Baron American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|
| ATP and sulfonylurea sensitivity of mutant ATP-sensitive [K.sup.+] channels in neonatal diabetes implications for pharmacogenomic therapy. : An article from: Diabetes Joseph C. Koster, Maria S. Remedi, Crystal Dao, Colin G. Nichols Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.(Emerging ... : An article from: Diabetes Care Julio Rosenstock, Danny Sugimoto, Poul Strange, John A. Stewart, Erika Soltes-Rak, George Dailey Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.(Clinical Care/Education/Nutrition) : An article from: Diabetes Care Michael N. Cook, Cynthia J. Girman, Peter P. Stein, Charles M. Alexander, Rury R. Holman American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|
| FDA advisory panel recommends muraglitazar for type 2 diabetes: the panel endorsed the drug's use alone and with metformin, but not combined with sulfonylureas.(Endocrinology): ... An article from: Internal Medicine News Miriam E. Tucker Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Beyond sulfonylureas: new oral medications in the treatment of NIDDM (Type II DM).(non-insulin dependent diabetes mellitus or type II diabetes mellitus): An article from: MedSurg Nursing Theresa Capriotti Jannetti Publications, Inc. Jannetti Publications, Inc. |
Sale Price: $5.95
|
| Sulfonylureas. (Medication Update).(Brief Article): An article from: Southern Medical Journal Mark Slagle Southern Medical Association The Gale Group Southern Medical Association |
Sale Price: $5.95
|
| Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity ... : An article from: Diabetes Care Antonio Ceriello, Don Johns, Mario Widel, David J. Eckland, Kathryn J. Gilmore, Meng H. Tan American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|
| Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients. : An article from: Diabetes Jens Friis Bak, Ole Schmitz, Niels Schwartz Sorenson, Oluf Pedersen American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|
email this page
print this page
bookmark this page
feedback on this page
